FR2925326B1 - Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines - Google Patents

Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines

Info

Publication number
FR2925326B1
FR2925326B1 FR0708979A FR0708979A FR2925326B1 FR 2925326 B1 FR2925326 B1 FR 2925326B1 FR 0708979 A FR0708979 A FR 0708979A FR 0708979 A FR0708979 A FR 0708979A FR 2925326 B1 FR2925326 B1 FR 2925326B1
Authority
FR
France
Prior art keywords
hydrolysat
maize
active ingredient
aquaporin synthesis
activator active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0708979A
Other languages
English (en)
Other versions
FR2925326A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0708979A priority Critical patent/FR2925326B1/fr
Publication of FR2925326A1 publication Critical patent/FR2925326A1/fr
Application granted granted Critical
Publication of FR2925326B1 publication Critical patent/FR2925326B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
FR0708979A 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines Expired - Fee Related FR2925326B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0708979A FR2925326B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0708979A FR2925326B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines

Publications (2)

Publication Number Publication Date
FR2925326A1 FR2925326A1 (fr) 2009-06-26
FR2925326B1 true FR2925326B1 (fr) 2010-02-26

Family

ID=39691268

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0708979A Expired - Fee Related FR2925326B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines

Country Status (1)

Country Link
FR (1) FR2925326B1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940291B1 (fr) 2008-12-23 2012-12-21 Isp Investments Inc Peptide derive d'hmg-coa reductase et composition cosmetique ou pharmaceutique le contenant
FR2940125B1 (fr) 2008-12-23 2013-03-22 Isp Investments Inc Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase
FR2944445B1 (fr) * 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
FR2944526B1 (fr) 2009-04-15 2013-05-10 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
FR2944527B1 (fr) * 2009-04-15 2013-05-10 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
FR2944446B1 (fr) * 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
FR2949781B1 (fr) * 2009-09-04 2015-10-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable d'activer la transglutaminase.
FR2951948A1 (fr) 2009-11-03 2011-05-06 Isp Investments Inc Utilisation d'un hydrolysat peptidique de mais en tant qu'agent actif stimulant la pousse du cheveu
FR2963234B1 (fr) 2010-07-29 2020-07-17 Isp Investments Inc Utilisation d'une composition comprenant un extrait peptidique de feves pour stimuler la pousse des cheveux
ES2396815B1 (es) 2011-05-23 2014-01-20 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención y usos de vesículas de membrana plasmática extraídas de plantas enriquecidas en proteínas transportadoras de membrana.
KR101839109B1 (ko) * 2016-09-22 2018-03-15 ㈜프론트바이오 퍼플콘 추출물을 함유하는 피부 질환의 예방 또는 치료용 약제학적 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771632B1 (fr) * 1997-12-01 2000-03-17 Seppic Sa Composition synergique comprenant au moins un lipoaminoacide et au moins un glycol; application en cosmetique
WO2001095728A1 (fr) * 2000-06-13 2001-12-20 Fd Management, Inc. Composition cosmetique pour peau agressee par des conditions extremes
FR2838343B1 (fr) * 2002-04-12 2004-05-28 Oreal Composition cosmetique sous forme d'emulsion multiple comprenant un agent tenseur
FR2900574B1 (fr) * 2006-05-05 2015-01-30 Oreal Composition comprenant un agent tenseur et un compose saccharidique
WO2008015342A2 (fr) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Utilisation d'un extrait vegetal en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes

Also Published As

Publication number Publication date
FR2925326A1 (fr) 2009-06-26

Similar Documents

Publication Publication Date Title
FR2925326B1 (fr) Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines
FR2925332B1 (fr) Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines
FR2925329B1 (fr) Utilisation d'un hydrolysat d'avoine en tant que principe actif activateur de la synthese des aquaporines
FR2925325B1 (fr) Utilisation d'un hydrolysat de colza en tant que principe actif activateur de la synthese des aquaporines
CL2008002694A1 (es) Combinaciones de principios activos que contienen derivados de acido tetramico sustituido con espirocetal; uso de las combinaciones para combatir plagas animales.
FR2925330B1 (fr) Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines
SV2009003376A (es) Derivados de aril isoxazolinas insecticidas
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
SV2010003472A (es) Compuestos de pirazol
CR20110354A (es) Compuestos de amidina sustituidas para combatir plagas de animales
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
CL2008000594A1 (es) Uso de compuestos derivados de heterociclos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad arterial coronaria entre otras enfermedades.
AR053334A1 (es) Pirazolilcarboxanilidas
UY33779A (es) ?2-(fenilamino)-1H-bencimidazol-5-carboxamidas novedosas?
ECSP11011183A (es) Compuestos orgánicos
ECSP11011184A (es) Compuestos orgánicos
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
UA106875C2 (uk) Тіадіазолілоксифеніламідини та їх застосування як фунгіцидів
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
ECSP088925A (es) Nitrilos espirocíclicos como inhibidores de proteasa
FR2925331B1 (fr) Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
CR20110269A (es) Lactamas como inhibidores de beta secretasa
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160831